Sanofi bids adieu to Aventis moniker
PARIS — French drug maker Sanofi-Aventis has shortened its name to Sanofi, the company said.
The company, which acquired Cambridge, Mass.-based biotech giant Genzyme for $20.1 billion earlier this year, had planned to vote at its shareholder meeting Friday.
According to published reports, the previous name was difficult to pronounce for people in many countries.
No comments found
Napo sues Salix over breach of collaboration agreement commitments
RALEIGH, N.C. — Napo Pharmaceuticals has filed a lawsuit against Salix Pharmaceuticals, alleging that the latter breached commitments under an agreement to develop and commercialize a proprietary gastrointestinal compound.
Salix said that Napo’s claims over its collaboration agreement concerning the development of crofelemer are without merit, adding that the drug maker plans to continue with the development and commercialization of crofelemer, in accordance with its past guidance and the terms of its collaboration agreement with Napo.
Crofelemer is Napo’s lead drug candidate, according to the company’s website, and is under development for gastrointestinal indications, including chronic diarrhea in patients living with HIV/AIDS.
Hopefully they can both work together to create a better drug than either could make individually. This is going to be a tough case. http://allherbalremedies.org/chronic-diarrhea-causes-treatment/
CDC, partners reinforce World Asthma Day’s message: Take control of asthma
ATLANTA — The number of people diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new Vital Signs report released earlier this week by the Centers for Disease Control and Prevention.
In 2009, nearly 1-in-12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about $53 billion in 2002 to about $56 billion in 2007, representing a 6% increase. The explanation for the growth in asthma rates is unknown.
"Despite the fact that outdoor air quality has improved [and that] we’ve reduced two common asthma triggers — secondhand smoke and smoking in general — asthma is increasing," stated Paul Garbe, chief of the CDC’s Air Pollution and Respiratory Health branch. "While we don’t know the cause of the increase, our top priority is getting people to manage their symptoms better."
Asthma diagnoses increased among all demographic groups between 2001 and 2009, though a higher percentage of children reported having asthma than adults (9.6%, compared with 7.7% in 2009). Diagnoses especially were high among boys (11.3%). The greatest rise in asthma rates was among black children (almost a 50% increase) from 2001 through 2009. As many as 17% of non-Hispanic black children had asthma in 2009, the highest rate among racial/ethnic groups.
Annual asthma medical expenses in the United States were $3,300 per person from 2002 to 2007. About 2-in-5 uninsured and 1-in-9 insured people with asthma could not afford their prescription medication.
"Asthma is a serious, lifelong disease that unfortunately kills thousands of people each year and adds billions to our nation’s healthcare costs," CDC director Thomas Frieden said. "We have to do a better job educating people about managing their symptoms and how to correctly use medicines to control asthma so they can live longer, more productive lives while saving healthcare costs."
This report coincided with World Asthma Day, an annual event sponsored by the Global Initiative for Asthma. This year’s theme is "You Can Control Your Asthma." Reducing asthma attacks and the human and economic costs of asthma are key priorities for the Department of Health and Human Services, and are the focus of a collaborative effort involving many parts of HHS.
No comments found